NCT01508416View on ClinicalTrials.gov

Study of Thrombin Generation During the 3 First Cycles of Chemotherapy in Patients With Newly Diagnosed Multiple Myeloma

CompletedOBSERVATIONAL
Enrollment

71

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

June 30, 2015

Conditions
Multiple Myeloma
Trial Locations (5)

42055

Service de Médecine Interne - CHU de Saint Etienne, Saint-Etienne

Service de rhumatologie - CHU de Saint Etienne, Saint-Etienne

42270

Service d'hématologie - ICL, Saint-Priest-en-Jarez

54000

CHU de Nancy, Nancy

63000

CHU de Clermont Ferrand, Clermont-Ferrand

All Listed Sponsors
collaborator

Institut de Cancérologie de la Loire

OTHER

collaborator

Groupe de Recherche sur la Thrombose

OTHER

lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER

NCT01508416 - Study of Thrombin Generation During the 3 First Cycles of Chemotherapy in Patients With Newly Diagnosed Multiple Myeloma | Biotech Hunter | Biotech Hunter